Periodontal Care and Glycemic Control in Diabetes
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00012688 |
Recruitment Status
:
Completed
First Posted
: March 16, 2001
Last Update Posted
: April 7, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus Poor Glycemic Control Peridontal Disease | Drug: Doxycycline HCI 10mg po for 2 weeks Procedure: Ultrasonic scaling with 0.12% chlorhexidine gluconate | Not Applicable |
Background:
Diabetes is a prevalent and costly disease among users of VA care. Goals of diabetes care include the prevention and/or delay of complications via adequate glycemic control. Improvements in periodontal status may also improve diabetes control.
Objectives:
This project will determine the efficacy of a program of periodontal screening and therapy in improving the level of glycemic control in poorly controlled diabetics.
Methods:
Status:
Subject accrual is complete. Data collection is ongoing.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Single |
Primary Purpose: | Treatment |
Official Title: | Periodontal Care and Glycemic Control in Diabetes |
Actual Study Completion Date : | September 2003 |
Arm | Intervention/treatment |
---|---|
Arm 1 | Drug: Doxycycline HCI 10mg po for 2 weeks Procedure: Ultrasonic scaling with 0.12% chlorhexidine gluconate |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients must have diabetes mellitus, and HbAlc >9, >8 teeth, and CPITN scores of 3 or 4 in, at least 2 sextants of the mouth, indicating moderate to high peridontal treatment need.
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00012688
United States, Massachusetts | |
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA | |
Bedford, Massachusetts, United States, 01730 |
Principal Investigator: | Judith A. Jones, DDS DSc MPH | Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA |
Publications of Results:
Responsible Party: | VA Office of Research and Development |
ClinicalTrials.gov Identifier: | NCT00012688 History of Changes |
Other Study ID Numbers: |
DII 99-206 |
First Posted: | March 16, 2001 Key Record Dates |
Last Update Posted: | April 7, 2015 |
Last Verified: | February 2007 |
Additional relevant MeSH terms:
Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases Chlorhexidine Chlorhexidine gluconate Doxycycline Anti-Infective Agents, Local |
Anti-Infective Agents Disinfectants Dermatologic Agents Anti-Bacterial Agents Antimalarials Antiprotozoal Agents Antiparasitic Agents |